AltMed Capital – AltMed Capital is a leading alternative medicine business incubator, IP aggregator and solutions provider.
*AltMed Capital is a subsidiary of Champignon Brands.
Anahit – Anahit is a Toronto-based company committed to bridging the gap between the emerging market potential and the developed market demand. The company focuses on the international cannabis and psilocybin industry, following a global seed to retail sale and retreat model.
ATAI Life Sciences – ATAI Life Sciences is dedicated to bringing innovation to mental healthcare, a field that has seen little progress since the development of selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) in the 1980s and 1990s, respectively.
Bright Minds – Bright Minds is creating the next generation of psychedelics to treat mental health disorders.
CaaMTech – CaaMTech is the foremost drug discovery and lead optimization company focused on engineering psychedelic drugs that meet the standards of modern medicine. CaaMTech is improving the health and happiness of humankind by creating and optimizing psychedelic compounds and formulations through rigorous science and continuous innovation.
Compass Pathways – Compass Pathways is a mental health care company that is dedicated to accelerating patient access to evidence-based innovation in mental health.
Cybin Therapeutics – Cybin Therapeutics is undertaking research and development to develop a psilocybin-based micro-dose drug formulation to treat mild mood disorders.
DemeRx – DemeRx is a clinical stage pharmaceutical development company advancing two lead drug candidates as medication-assisted therapies for opioid addiction.
Eleusis – Eleusis is a clinical stage life science company dedicated to unlocking the therapeutic potential of serotonin 2Areceptor agonists, commonly referred to as psychedelics, through the mitigation and management of psychoactivity.
Entheogenix Biosciences – Entheogenix Biosciences is a biotech company dedicated to advancing psychedelic research for the development of better medicines for mental health diseases such as depression, bipolar disorder, and schizophrenia.
Entheon Biomedical – Entheon Biomedical is a psychedelic R&D company focused on addressing the lack of treatment options available to those suffering from addictive disorders.
Field Trip – Field Trip is a first-of-its-kind venture that is blending operational execution with strategic investing across all aspects of the psychedelics value chain — from basic research on botanical psychedelics to operation of world class clinics focused on psychedelics-assisted therapies.
GABA Therapeutics – GABA Therapeutics is developing GRX-917, an anxiety medication as effective as benzodiazepines like Xanax, but with minimal to no side effects. The drug’s dual mechanism of action may also benefit a broad range of neuropsychiatric and neurological disorders.
Hive – Hive is bringing new therapies and positive change focused retreats to Europe.
Lophora – Lophora is a drug-development start-up developing new rapid-acting drugs for central nervous system diseases including treatment-resistant depression.
Maya – Maya is a Colorado Public Benefit Corporation (PBC), which means their team members, advisors, investors & supporters are aligned towards purpose above profit. Maya is laying the foundations of a global environment for psychedelic compounds to be used safely & legitimately. Maya helps psychedelic practitioners to lead more effectively, ease their workload, and serve more people.
Mindbloom – Mindbloom’s ketamine therapy platform helps licensed psychiatric clinicians achieve better outcomes for their patients with lower costs, greater convenience, and an artfully crafted experience.
Mindset Pharma – Mindset Pharma is a drug discovery business focused on creating novel and patentable psychedelic compounds for the treatment of neurological and psychiatric disorders.
MoodMonitor – MoodMonitor is a secure, reliable, easy-to-use reporting and monitoring tool trusted by over 50 ketamine clinics and their patients nationwide.
Mycotopia Therapy – Mycotopia Therapy provides technology-focused, data-driven, and medical-based solutions dealing with anxiety, depression, bipolar disorders, PTSD, ADHD, Autism, and addictions.
*The Mycotopia Therapy Team is an extension of the team at EHAVE.
NeonMind – NeonMind is dedicated to the improvement of human life through the advancement of science to engage the mind to heal the body.
Novo Formulations – Novo formulations is a Specialty Biotechnology company that focuses on novel and innovative delivery system platforms for the pharmaceutical and nutraceutical industries.
Numinus – Numinus is creating a network of transformative healing centres across North America. Professional therapists and integrative health professionals guide people in the use of psychedelics, supportive therapies and sophisticated technologies to help them heal, connect and grow — in a safe, controlled therapeutic environment.
Octarine – Octarine Bio is a synthetic biology company developing superior cannabinoid and psilocybin derivatives.
OLP Therapeutics – OLP Therapeutics is a world-leading source for collaborative projects in natural psilocybin mushroom medicines, research, therapeutic training, and cultivation.
OptoSom – OptoSom is an organization committed to working with governments, healthcare providers, and individuals to make psilocybin an alternative therapy for those suffering from addiction and psychological illnesses such as anxiety, depression, PTSD, and OCD.
Orthogonal – Orthogonal’s mission is to give people access to nature’s most effective health solutions while setting the standard of a new “Farma”, Food as Medicine.
Perception Neuroscience – is a biopharmaceutical company developing arketamine therapy for neuropsychiatric diseases. Perception’s mission is to provide substantially more effective treatment solutions to serious psychiatric disorders.
Psilocin Pharma Corp. – Psilocin Pharma Corp. has developed production solutions for the active compound Psilocybin, with intellectual property covering methods of production of Psilocybin based formulations.
*Psilocin Pharma Corp. was acquired by Revive Therapeutics on March 5, 2020.
Psychtech – Psychtech is one of the world’s leading developers of psychometric tests and software for the workplace.
Silo Wellness – Silo Wellness understands that supply chain, technology, formulation, strategic partnerships and first-to-market branding will be essential for emerging markets in the mushroom/psilocybin and DMT/ayahuasca therapy and functional mushroom industries.
Small Pharma – Many valuable drug development opportunities, either from academia or from discovery-focused biotech companies, lose their way in development and never reach the patients who should benefit from them. Small Pharma is dedicated to identifying these opportunities and ensuring that the value in the underlying pharmaceutical assets is preserved.
Synthesis – Synthesis is a legal, medically supervised, psilocybin retreat center for professionals to experience personal growth, emotional breakthroughs and spiritual development.
Tassili Life Sciences – Tassili Life Sciences, Corp. in collaboration with multiple university research institutes intends to prove that clinical and physiological effectiveness in post concussion syndrome, PTSD and OCD are enhanced by timely measured dosages of Psilocybin+CBD with superior clinical results as measured by objective outcomes.
*Tassili Life Sciences has been acquired by Champignon Brands.
Think Myko – Think Myco is a vertically integrated mycology technology company that is innovating across the entire value chain, developing sustainable, cutting-edge solutions for the world’s needs.
Verrian – Verrian is focused on validating promising pre-clinical evidence for treatment of addiction through natural psychedelics.
Zamnesia – The Smartshop at Zamnesia carries one of the biggest assortments of natural psychedelics, power herbs, energisers, and aphrodisiacs on the web.